The collagen prolyl hydroxylases are bifunctional growth regulators in melanoma
File(s)Accepted JID manuscript Oct 2018.pdf (648.2 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Appropriate post-translational processing of collagen requires prolyl hydroxylation, catalyzed by the prolyl 3- (C-P3H) and prolyl 4- (C-P4H) hydroxylases is essential for normal cell function. Here we have investigated the expression, transcriptional regulation and function of the C-P3H and C-P4H families in melanoma. We show that the CP3H family exemplified by Leprel1 and Leprel2 are subject to methylation-dependent transcriptional silencing in primary and metastatic melanoma consistent with a tumour suppressor function. In contrast, although there is transcriptional silencing of P4HA3 in a sub-set of melanomas, the CP4H family members P4HA1, P4HA2 and P4HA3 are often over-expressed in melanoma, expression being prognostic of worse clinical outcomes. Consistent with tumour suppressor function, ectopic expression of Leprel1 and Leprel2 inhibits melanoma proliferation, whereas P4HA2 and P4HA3 increase proliferation and particularly invasiveness of melanoma cells. Pharmacological inhibition with multiple selective C-P4H inhibitors reduces proliferation and inhibits invasiveness of melanoma cells. Together, our data identify the C-P3H and C-P4H families as potentially important regulators of melanoma growth and invasiveness and suggest that selective inhibition of C-P4H is an attractive strategy to reduce the invasive properties of melanoma cells.
Date Issued
2019-05
Date Acceptance
2018-10-01
Citation
Journal of Investigative Dermatology, 2019, 139 (5), pp.1118-1126
ISSN
0022-202X
Publisher
Elsevier
Start Page
1118
End Page
1126
Journal / Book Title
Journal of Investigative Dermatology
Volume
139
Issue
5
Copyright Statement
© 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Brain Tumour Research Campaign
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30452903
PII: S0022-202X(18)32822-7
Grant Number
N/A
Subjects
Melanoma
Prolyl hydroxylases
biomarker
epigenetics
methylation
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2018-11-16